Table 4 Numbers of intravitreal anti-VEGF injections and PDT sessions

From: Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy

 

Treatment group

p a

PDT + anti-VEGF

PDT

anti-VEGF

Number of injections

(all patients)

   

  Total

8.5 ± 5.6

N/A

10.5 ± 4.8

0.3828

  During first year

5.5 ± 2.4

N/A

6.0 ± 2.4

0.5990

  Annual rate

4.6 ± 2.1

N/A

5.1 ± 2.3

0.6243

Number of injections

(PDT at baseline)

   

  Total

7.8 ± 5.8

N/A

10.5 ± 4.8

0.2611

  During first year

4.7 ± 2.0

N/A

6.0 ± 2.4

0.1680

  Annual rate

4.3 ± 2.0

N/A

5.1 ± 2.3

0.4198

Number of PDT sessions

(all patients)

   

  Total

1.2 ± 0.5

1.7 ± 0.7

N/A

0.0402

  Annual rate

0.8 ± 0.5

1.3 ± 0.7

N/A

0.0455

  1. Numbers of treatments are all presented as mean ± standard deviation
  2. N/A not applicable
  3. aComparison of the number of treatments between the two groups in each row as applicable. Two-tailed unpaired Student’s t test was used for the number of injections and two-tailed Mann–Whitney test was used for the number of PDT sessions
Back to article page